B. Teobald

Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy.

A. Bailey, David Cox, P. Leff, 1999, Journal of medicinal chemistry.

From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis.

P. Leeson, B. Springthorpe, P. Barton, 2007, Bioorganic & medicinal chemistry letters.

Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists.

J. Unitt, Bryan E. Roberts, A. Baxter, 2017, ACS medicinal chemistry letters.

The use of temporary tethers in the meta photocycloaddition reaction

P. Hitchcock, Clive S. Penkett, B. Teobald, 2004 .

The Nicholas reaction: the use of dicobalt hexacarbonyl-stabilised propargylic cations in synthesis

B. Teobald, Barry Teobald, 2002 .

Lead optimisation of pyrazoles as novel FPR1 antagonists.

M. Wenlock, Bryan E. Roberts, Tony R Cook, 2012, Bioorganic & medicinal chemistry letters.

The discovery of AZD9164, a novel muscarinic M3 antagonist.

Keith Bowers, Ken Grime, Helen Edwards, 2011, Bioorganic & medicinal chemistry letters.

From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease

Stephen R. Morairty, Robert T. Smith, G. Dawson, 2021, Cell.